📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients. (2021)

First Author: Harden PN

Attributed to: The TWO Study: A Phase II trial of regulatory T cells in renal transplantation - can we achieve sirolimus monotherapy? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/ajt.16395

PubMed Identifier: 33171020

Publication URI: http://europepmc.org/abstract/MED/33171020

Type: Journal Article/Review

Volume: 21

Parent Publication: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Issue: 4

ISSN: 1600-6135